11.700
+1,74%
2026-10-19
Fundamental Analysis
96 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +1383.3% | +904.2% | 2 / 3 | +86.4% | +28.43 pp | +24.63 pp | +90.5% | 0.79 | 3.96 | 2.213 | +86,4% | 623 | +1.383,3% | 3.96 | 263.31 | −98,5% |
| Pts | 12 | 12 | 8 | 12 | 12 | 12 | 12 | 12 | 12 | |||||||
Valuation annotation:Price: 11.700 (close price on 2026-10-19)EPS (TTM): 2.952
Financial charts
1.Revenue & growth
VND bn2.213Q2/26
1.Revenue & growth
VND bn2.213Q2/26
2.Profit & growth
VND bn626Q2/26
3.Profit mix (Penman)
VND bn1.019Q2/26
4.Margins & cost structure
%26.2%Q2/26
5.Returns & cash cycle
% · days38.5%Q2/26
6.Earnings quality & cash
VND bn1.575Q2/26
7.Asset structure
VND bn5.703Q2/26
8.Funding & debt health
VND bn · times5.703Q2/26
9.Revenue backlog
VND bn59,1Q2/26
10.Valuation
times · %4,0×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %2.299Q2/26
Adjusted EPS growth, latest quarter
14,9× higher
Average adjusted EPS growth, 3 quarters
906%
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26